5-19 | Phumeza TISILE, co-author of the DR-TB Manifesto* and XDR-TB survivor, delivers urgent plea to World Health Assembly delegates on behalf of 50,000 supporters worldwide On the eve of the World Health Assembly adopting an ambitious 20-year global plan to address tuberculosis (TB) and drug-resistant TB (DR-TB), MSF urges governments to focus intensely on improving DR-TB testing and care over the next 12 months.
3-24 | 24th March is the World Tuberculosis (TB) Day. A new briefing paper by Médecins Sans Frontières (MSF) outlines why the alarming spread of deadly strains of drug-resistant tuberculosis (DR-TB) is one of the biggest global health threats we face today. It calls on governments, pharmaceutical companies and researchers to mobilise urgently to save more lives and find new treatments to stem the virulent disease. Every year, around eight million people worldwide fall ill with tuberculosis (TB) and 1.3 million people die from the infectious airborne disease.
3-20 |
People living with MDR-TB and their healthcare providers call for urgent action
3-14 |
“I felt like I had bugs crawling on the inside of my head”. The highly toxic pills and daily injections that Mary was taking made her vomit, lose her appetite and hallucinate. And it was MSF doctors who were telling her she had to keep on taking them, had to bear all those “side effects” in the hope that she would get well eventually. It took two years. But finally, Mary MARIZANI became the first MSF patient in Zimbabwe to be cured of multidrug resistant tuberculosis. “I had to pass through hell to get to heaven”.
1-2 | MSF calls for rapid registration in countries with high drug-resistant tuberculosis burdenMédecins Sans Frontières (MSF) welcomed the approval by the US Food and Drug Administration of bedaquiline, the first new drug active against tuberculosis (TB) to be registered since 1963.